Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
alarelin
- Development stage
- Unknown
- Lead developer
- Shanghai Soho-YiMing Pharmaceuticals
- Modality
- Peptides
- Administration
- Subcutaneous, Intramuscular
01
Overview
Alarelin is a synthetic nonapeptide and a potent agonist of the gonadotropin-releasing hormone (GnRH) receptor. By binding to GnRH receptors in the pituitary gland, it initially stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Prolonged administration leads to receptor downregulation and desensitization, effectively suppressing the pituitary-gonadal axis and reducing the production of sex steroids. Manufactured as an active pharmaceutical ingredient (API) by Soho-Yiming Pharmaceuticals, it is utilized in the treatment of hormone-dependent conditions such as endometriosis and uterine fibroids, as well as in fertility protocols for ovulation induction. It is also widely used in research and veterinary applications due to its high biological activity compared to natural GnRH.
- Brand names
- 阿拉瑞林
- Other names
- alarelin acetateAlarelinum
02
Targets
GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on alarelin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on alarelin.